Trademark search for:

PLENADREN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2017-02-24 — Application filed
2017-02-28 — Application filed
2017-03-03 — Application filed
2017-05-19 — Assigned to examiner
2017-05-24 — Approved for pub - principal register
2017-06-14 — Notification of notice of publication e-mailed
2017-07-04 — Published for opposition
2017-07-04 — Official gazette publication confirmation e-mailed
2017-09-19 — Registered-principal register
2021-09-09 — Teas change of owner address received
2021-09-09 — Attorney/dom.rep.revoked and/or appointed
2021-09-09 — Teas change of domestic representatives address
2021-09-09 — Teas change of correspondence received
2021-09-09 — Applicant/correspondence changes (non-responsive) entered
2021-09-09 — Teas revoke/app/change addr of atty/dom rep received
2022-09-19 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2023-06-14 — Automatic update of assignment of ownership
2024-03-29 — Cancelled sec. 8 (6-yr)
2024-03-29 — Final status recorded

Owner Information

TAKEDA PHARMA AB
STOCKHOLM SE

DuoCort Pharma AB
Helsingborg SE

DuoCort Pharma AB
SE-252 20 Helsingborg SE

Correspondent

Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP
875 Third Avenue
c/o IP Services NYC
New York, NY 10022

Filing Details

Filing Date:
2017-02-24

Status Date:
2024-03-29

Category:
Pharmaceuticals

Filing Year:
2010

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.